A citation-based method for searching scientific literature

Ridge G Weston, Paul J Fitzgerald, Brendon O Watson. Front Psychiatry 2021
Times Cited: 4







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019.
Walter S Marcantoni, Bertine Sandra Akoumba, Maggy Wassef, Julie Mayrand, Hinatea Lai, Stéphane Richard-Devantoy, Sylvie Beauchamp. J Affect Disord 2020
49
50

Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
Tung-Ping Su, Mu-Hong Chen, Cheng-Ta Li, Wei-Chen Lin, Chen-Jee Hong, Ralitza Gueorguieva, Pei-Chi Tu, Ya-Mei Bai, Chih-Ming Cheng, John H Krystal. Neuropsychopharmacology 2017
108
50

Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers.
Dmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, Atul Khullar, Mary-Anne MacKay, Glen B Baker, Serdar M Dursun. Ther Adv Psychopharmacol 2020
48
50

Sex Differences in the Sustained Effects of Ketamine on Resilience to Chronic Stress.
Tracy Okine, Ryan Shepard, Elise Lemanski, Laurence Coutellier. Front Behav Neurosci 2020
11
50

Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.
Marlene P Freeman, George I Papakostas, Bettina Hoeppner, Erica Mazzone, Heidi Judge, Cristina Cusin, Sanjay Mathew, Gerard Sanacora, Dan Iosifescu, Charles DeBattista,[...]. J Psychiatr Res 2019
29
50

Sex differences in the antidepressant-like effects of ketamine.
Nicole Carrier, Mohamed Kabbaj. Neuropharmacology 2013
168
50


Ketamine and peripheral inflammation.
Marc De Kock, Sebastien Loix, Patricia Lavand'homme. CNS Neurosci Ther 2013
107
25

Maintenance of antidepressant and antisuicidal effects by D-cycloserine among patients with treatment-resistant depression who responded to low-dose ketamine infusion: a double-blind randomized placebo-control study.
Mu-Hong Chen, Chih-Ming Cheng, Ralitza Gueorguieva, Wei-Chen Lin, Cheng-Ta Li, Chen-Jee Hong, Pei-Chi Tu, Ya-Mei Bai, Shih-Jen Tsai, John H Krystal,[...]. Neuropsychopharmacology 2019
31
25

The effects of ketamine on typical and atypical depressive symptoms.
L T Park, D A Luckenbaugh, S J Pennybaker, M A Hopkins, I D Henter, M S Lener, B Kadriu, E D Ballard, C A Zarate. Acta Psychiatr Scand 2020
9
25

Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats.
Takumi Taniguchi, Hiroko Kanakura, Yasuhiro Takemoto, Yoko Kidani, Ken Yamamoto. Tohoku J Exp Med 2003
32
25

Treatment-resistant depression.
Daniel Souery, George I Papakostas, Madhukar H Trivedi. J Clin Psychiatry 2006
220
25

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.
J W Murrough, L Soleimani, K E DeWilde, K A Collins, K A Lapidus, B M Iacoviello, M Lener, M Kautz, J Kim, J B Stern,[...]. Psychol Med 2015
178
25


Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.
D D Kiraly, S R Horn, N T Van Dam, S Costi, J Schwartz, S Kim-Schulze, M Patel, G E Hodes, S J Russo, M Merad,[...]. Transl Psychiatry 2017
99
25

The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
Roger S McIntyre, Nelson B Rodrigues, Orly Lipsitz, Flora Nasri, Hartej Gill, Leanna Mw Lui, Mehala Subramaniapillai, Kevin Kratiuk, Kayla Teopiz, Roger Ho,[...]. J Psychopharmacol 2021
5
25

Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression.
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Taylor Hatchard, Abigail Ortiz, Meagan Birmingham, Olabisi Owoeye, Lisa A Batten, Pierre Blier. Neuropsychopharmacology 2020
35
25

Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity.
Francesca Calabrese, Andrea C Rossetti, Giorgio Racagni, Peter Gass, Marco A Riva, Raffaella Molteni. Front Cell Neurosci 2014
293
25

Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Nuray Çakici, Arjen L Sutterland, Brenda W J H Penninx, Virgil A Dalm, Lieuwe de Haan, Nico J M van Beveren. Brain Behav Immun 2020
47
25

The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis.
Samuel T Wilkinson, Elizabeth D Ballard, Michael H Bloch, Sanjay J Mathew, James W Murrough, Adriana Feder, Peter Sos, Gang Wang, Carlos A Zarate, Gerard Sanacora. Am J Psychiatry 2018
305
25

Alterations of multiple peripheral inflammatory cytokine levels after repeated ketamine infusions in major depressive disorder.
Yanni Zhan, Yanling Zhou, Wei Zheng, Weijian Liu, Chengyu Wang, Xiaofeng Lan, Xiurong Deng, Yan Xu, Bin Zhang, Yuping Ning. Transl Psychiatry 2020
26
25


Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: A randomized, double-blind control study.
Mu-Hong Chen, Cheng-Ta Li, Wei-Chen Lin, Chen-Jee Hong, Pei-Chi Tu, Ya-Mei Bai, Chih-Ming Cheng, Tung-Ping Su. Psychiatry Res 2018
67
25

The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors.
Casimir de Rham, Sylvie Ferrari-Lacraz, Sabrina Jendly, Gregory Schneiter, Jean-Michel Dayer, Jean Villard. Arthritis Res Ther 2007
102
25

A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression.
Paulo R Shiroma, Paul Thuras, Joseph Wels, C Sophia Albott, Christopher Erbes, Susannah Tye, Kelvin O Lim. Transl Psychiatry 2020
25
25

Effects of Ketamine on Levels of Inflammatory Cytokines IL-6, IL-1β, and TNF-α in the Hippocampus of Mice Following Acute or Chronic Administration.
Yanning Li, Ruipeng Shen, Gehua Wen, Runtao Ding, Ao Du, Jichuan Zhou, Zhibin Dong, Xinghua Ren, Hui Yao, Rui Zhao,[...]. Front Pharmacol 2017
56
25


Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
Maurizio Fava, A John Rush, Jonathan E Alpert, G K Balasubramani, Stephen R Wisniewski, Cheryl N Carmin, Melanie M Biggs, Sidney Zisook, Andrew Leuchter, Robert Howland,[...]. Am J Psychiatry 2008
602
25

Cytokines in clinical cancer immunotherapy.
Pedro Berraondo, Miguel F Sanmamed, María C Ochoa, Iñaki Etxeberria, Maria A Aznar, José Luis Pérez-Gracia, María E Rodríguez-Ruiz, Mariano Ponz-Sarvise, Eduardo Castañón, Ignacio Melero. Br J Cancer 2019
376
25

Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Minkyung Park, Laura E Newman, Philip W Gold, David A Luckenbaugh, Peixiong Yuan, Rodrigo Machado-Vieira, Carlos A Zarate. J Psychiatr Res 2017
52
25

The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review.
Koen Demyttenaere, Zeno Van Duppen. Int J Neuropsychopharmacol 2019
30
25

Association of plasma VEGF levels and the antidepressant effects of ketamine in patients with depression.
Wei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Su-Miao Zhou, Su Yan, Ming-Zhe Yang, Sha Nie, Yu-Ping Ning. Ther Adv Psychopharmacol 2021
4
25

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A Batten, Pierre Blier. Am J Psychiatry 2019
152
25

Postnatal Antioxidant and Anti-inflammatory Treatments Prevent Early Ketamine-Induced Cortical Dysfunctions in Adult Mice.
Maria Bove, Paolo Tucci, Stefania Dimonte, Luigia Trabace, Stefania Schiavone, Maria Grazia Morgese. Front Neurosci 2020
7
25

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials.
Joanna Kryst, Paweł Kawalec, Alicja Mikrut Mitoraj, Andrzej Pilc, Władysław Lasoń, Tomasz Brzostek. Pharmacol Rep 2020
45
25

Plasma BDNF concentrations and the antidepressant effects of six ketamine infusions in unipolar and bipolar depression.
Wei Zheng, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Su-Miao Zhou, Su Yan, Yu-Ping Ning. PeerJ 2021
6
25

Repeated ketamine treatment induces sex-specific behavioral and neurochemical effects in mice.
Connor Thelen, Jonathon Sens, Joseph Mauch, Radhika Pandit, Pothitos M Pitychoutis. Behav Brain Res 2016
45
25

ProBDNF Signaling Regulates Depression-Like Behaviors in Rodents under Chronic Stress.
Yin-Yin Bai, Chun-Sheng Ruan, Chun-Rui Yang, Jia-Yi Li, Zhi-Long Kang, Li Zhou, Dennis Liu, Yue-Qing Zeng, Ting-Hua Wang, Chang-Fu Tian,[...]. Neuropsychopharmacology 2016
72
25

A TrkB receptor agonist N-acetyl serotonin provides cerebral protection after traumatic brain injury by mitigating apoptotic activation and autophagic dysfunction.
Tongyu Rui, Zufeng Wang, Qianqian Li, Haochen Wang, Tao Wang, Mingyang Zhang, Luyang Tao, Chengliang Luo. Neurochem Int 2020
6
25

Ketamine for depression: where do we go from here?
Marije Aan Het Rot, Carlos A Zarate, Dennis S Charney, Sanjay J Mathew. Biol Psychiatry 2012
254
25

Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
Rotimi Adegbenga Owolabi, Moses Atanda Akanmu, Oluwole Isaac Adeyemi. Neurosci Lett 2014
20
25

Antidepressant actions of ketamine: from molecular mechanisms to clinical practice.
Lisa M Monteggia, Carlos Zarate. Curr Opin Neurobiol 2015
105
25


Ethanol-induced caspase-3 activation in the in vivo developing mouse brain.
John W Olney, Tatyana Tenkova, Krikor Dikranian, Louis J Muglia, Walter J Jermakowicz, Cleta D'Sa, Kevin A Roth. Neurobiol Dis 2002
199
25

Effect of ketamine on binge drinking patterns in crossed high alcohol-preferring (cHAP) mice.
Cherish E Ardinger, Garrett Winkler, Christopher C Lapish, Nicholas J Grahame. Alcohol 2021
2
50


Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases.
Carol M Troy, Jonathan E Friedman, Wilma J Friedman. J Biol Chem 2002
155
25

Truncated TrkB: beyond a dominant negative receptor.
Barbara M Fenner. Cytokine Growth Factor Rev 2012
137
25

Hippocampal long-term depression is required for the consolidation of spatial memory.
Yuan Ge, Zhifang Dong, Rosemary C Bagot, John G Howland, Anthony G Phillips, Tak Pan Wong, Yu Tian Wang. Proc Natl Acad Sci U S A 2010
197
25

Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain.
Xiaoju Zou, Tucker A Patterson, Rebecca L Divine, Natalya Sadovova, Xuan Zhang, Joseph P Hanig, Merle G Paule, William Slikker, Cheng Wang. Int J Dev Neurosci 2009
170
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.